Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pierre Fabre
Pharma
Atara hit with cell therapy clinical hold after FDA inspection
After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline of T-cell immunotherapies.
Fraiser Kansteiner
Jan 21, 2025 9:59am
Atara, Pierre Fabre hit a hurdle with Ebvallo in the US
Jan 16, 2025 9:36am
Pierre Fabre commits up to $640M in T-cell deal with Atara
Nov 3, 2023 11:04am
French CMO Fareva adds 4 facilities, more than 1,000 employees
Nov 10, 2020 9:04am
Is Puma off the M&A target list after Nerlynx licensing deal?
Apr 2, 2019 11:58am
NICE clears Pierre Fabre's targeted melanoma combo
Jan 21, 2019 10:09am
